Adults treated with 14 days of intravenous injections of ginkgo diterpene lactone meglumine (GDLM) -- a combination of biologically active components of ginkgo biloba -- after an ischemic (clot-caused ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback